Page 2 - Consort Medical Plc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article
Share this article
ResearchAndMarkets.com s offering.
The Global Pharmaceutical Contract Development & Manufacturing Market is estimated to be USD 100 Bn in 2020 and is expected to reach USD 142.2 Bn by 2025 growing at a CAGR of 7.3%.
One of the reasons for the increase in the pharmaceutical contract development and manufacturing industry is the growth of developing biotech. Most of the companies are continuously involved in the development of complex drug compounds to address a specific disease.
Most of the companies lack the infrastructure required for formulation, clinical, and regulatory agency submission. A partnership with a pharmaceutical contract manufacturer can provide another viable option. By working cooperatively, a biotech company, a donor company, and a pharmaceutical contract manufacturer can move a product into the global markets. ....

United States , Sagimet Biosciences , Asia Pacific , Laura Wood , Contract Development , Almac Group , International Corporation , Famar Health Care Services , V Biosciences Inc , Vetter Pharma International Gmb , Evonik Industries , Abbvie Inc , Veter Pharma International Gmb , Generic Pharmaceutical Companies , Porter Five Forces Analysis , Samsung Bioepis Co , Siegfried Holding , Quanticate Ltd , Office Hours Call , Consort Medical Plc , Research Methodology , Oral Liquid Manufacturing Services , Holdings Co , Catalent Inc , Thermo Fisher Scientific Inc , Jubilant Life Sciences Ltd ,